Additional Information

Description
Wegovy® (semaglutide) injection is an FDA-approved prescription medication. It has undergone rigorous FDA evaluation for safety, efficacy, and quality. This product is supplied with a full FDA-approved prescribing label.

Wegovy® contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, and is indicated for chronic weight management. The 0.25 mg/0.5 mL pen is intended for initial dose escalation according to the approved prescribing schedule.

Dispensed only pursuant to a valid prescription. For subcutaneous injection only. Dosing must be determined and supervised by a qualified healthcare professional in accordance with the official prescribing information.

Important Safety Notice: This is an FDA-approved drug with a established safety and efficacy profile. Patients should be counseled on the potential side effects, including serious ones such as thyroid C-cell tumors, pancreatitis, and gallbladder disease, as described in the Boxed Warning and full prescribing information.